15
Participants
Start Date
October 14, 2024
Primary Completion Date
March 31, 2028
Study Completion Date
March 31, 2028
Metreleptin
Metreleptin is a recombinant human leptin analog that is indicated as an adjunct to diet as replacement therapy to treat the complications of leptin deficiency
NOT_YET_RECRUITING
Flourish Research, Boca Raton
NOT_YET_RECRUITING
University of Alabama, Birmingham
RECRUITING
University of Michigan, Ann Arbor
RECRUITING
The Medical College of Wisconsin, Milwaukee
RECRUITING
UT Southwestern Medical Center, Dallas
RECRUITING
Massachusetts General Hospital, Boston
Lead Sponsor
Amryt Pharma
INDUSTRY